{"id":"https://openalex.org/W2000964237","doi":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","title":"Complete Response to Adriamycin and Ifosfamide in a Patient With Sarcomatoid Renal Cell Carcinoma","display_name":"Complete Response to Adriamycin and Ifosfamide in a Patient With Sarcomatoid Renal Cell Carcinoma","alternate_titles":[],"publication_year":2005,"publication_date":"2005-01-31","ids":{"openalex":"https://openalex.org/W2000964237","doi":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","mag":"2000964237","pmid":"https://pubmed.ncbi.nlm.nih.gov/15685046"},"language":"en","primary_location":{"id":"doi:10.1097/01.coc.0000139938.76332.6e","doi":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000964237"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084045313","display_name":"Mohammad H. Rashid","orcid":"https://orcid.org/0000-0003-1056-4910","observed_orcids":["https://orcid.org/0000-0003-1056-4910"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mohammad H. Rashid","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, South Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, Medical University of South Carolina, Charleston, South Carolina, USA","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108417399","display_name":"Cynthia T. Welsh","orcid":"https://orcid.org/0009-0001-4638-2425","observed_orcids":["https://orcid.org/0009-0001-4638-2425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia T. Welsh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110342396","display_name":"Nabil K. Bissada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nabil K. Bissada","raw_affiliation_strings":["Department of Urology, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072659004","display_name":"Uzair B. Chaudhary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Uzair B. Chaudhary","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology and \u2020Department of Pathology, Medical University of South Carolina, Charleston, South Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology and \u2020Department of Pathology, Medical University of South Carolina, Charleston, South Carolina","institution_ids":["https://openalex.org/I153297377"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072659004","https://openalex.org/A5084045313"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":null,"apc_paid":null,"fwci":1.0338,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.76483186,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"28","issue":"1","first_page":"107","last_page":"108"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sarcomatoid-renal-cell-carcinoma","display_name":"sarcomatoid renal cell carcinoma","score":1.0},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.953000009059906},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9319999814033508},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6980000138282776},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9259999990463257},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.8460000157356262},{"id":"https://openalex.org/keywords/prognostic-subgroups","display_name":"prognostic subgroups","score":0.699999988079071},{"id":"https://openalex.org/keywords/tumor-biology","display_name":"tumor biology","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.9572564363479614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8770824670791626},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5958811640739441},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5621431469917297},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5133406519889832},{"id":"https://openalex.org/C2780808757","wikidata":"https://www.wikidata.org/wiki/Q7423598","display_name":"Sarcomatoid carcinoma","level":3,"score":0.47499457001686096},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43235641717910767},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4197220504283905},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3714728057384491},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3296627104282379},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.06697756052017212}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.coc.0000139938.76332.6e","doi":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.coc.0000139938.76332.6e","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:15685046","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15685046","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1931162541","https://openalex.org/W2025597777","https://openalex.org/W2045778615","https://openalex.org/W2164584861","https://openalex.org/W4319293008"],"related_works":["https://openalex.org/W2120911976","https://openalex.org/W2082746319","https://openalex.org/W4319293008","https://openalex.org/W2045778615","https://openalex.org/W2113140565","https://openalex.org/W2468390070","https://openalex.org/W2041701469","https://openalex.org/W1969878537","https://openalex.org/W1931162541","https://openalex.org/W2136088692"],"abstract_inverted_index":{"Sarcomatoid":[0],"renal":[1],"cell":[2],"carcinoma":[3],"(SRCC)":[4],"is":[5],"a":[6,21,26,32],"heterogeneous":[7],"disease":[8,76],"with":[9,28,48],"generally":[10],"unreliable":[11],"response":[12,36],"to":[13,37,45,65],"various":[14],"therapies":[15],"in":[16,24,68],"clinical":[17],"studies.":[18],"We":[19,42],"illustrate":[20],"case":[22],"report":[23],"which":[25],"woman":[27],"metastatic":[29],"SRCC":[30,63],"had":[31],"complete":[33],"and":[34,39],"durable":[35],"adriamycin":[38],"ifosfamide":[40],"chemotherapy.":[41],"find":[43],"this":[44],"be":[46,66],"incongruous":[47],"expectations":[49],"from":[50],"some":[51],"recently":[52],"published":[53],"data.":[54],"It":[55],"underscores":[56],"the":[57,60,75],"fact":[58],"that":[59],"biology":[61],"of":[62,74],"needs":[64],"studied":[67],"more":[69],"detail":[70],"for":[71],"further":[72],"subcataloging":[73],"into":[77],"diverse":[78],"prognostic":[79],"categories.":[80]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000964237","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
